Heribert Juergens

5.5k total citations · 1 hit paper
60 papers, 3.3k citations indexed

About

Heribert Juergens is a scholar working on Pulmonary and Respiratory Medicine, Pathology and Forensic Medicine and Oncology. According to data from OpenAlex, Heribert Juergens has authored 60 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Pulmonary and Respiratory Medicine, 22 papers in Pathology and Forensic Medicine and 17 papers in Oncology. Recurrent topics in Heribert Juergens's work include Sarcoma Diagnosis and Treatment (37 papers), Lymphoma Diagnosis and Treatment (21 papers) and Cardiac tumors and thrombi (14 papers). Heribert Juergens is often cited by papers focused on Sarcoma Diagnosis and Treatment (37 papers), Lymphoma Diagnosis and Treatment (21 papers) and Cardiac tumors and thrombi (14 papers). Heribert Juergens collaborates with scholars based in Germany, United States and Netherlands. Heribert Juergens's co-authors include Paul A. Meyers, Ian Lewis, Uta Dirksen, Claudia Rössig, Sibylle Pscherer, Bianca Altvater, Silke Landmeier, Andreas Ranft, Georg Gosheger and Sareetha Kailayangiri and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

Heribert Juergens

59 papers receiving 3.3k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Osteosarcoma treatment – Where do we stand? A state of the art review

2013 1.0k citations Paul A. Meyers, Ian Lewis et al. Cancer Treatment Reviews profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Heribert Juergens	1.6k	1.1k	1.0k	593	531	60	3.3k
Sandra J. Strauss	1.5k 0.9×	1.3k 1.2×	844 0.8×	418 0.7×	223 0.4×	94	3.1k
Stefania Benini	1.7k 1.1×	864 0.8×	1.4k 1.3×	595 1.0×	218 0.4×	89	3.1k
Alexander J. Chou	1.1k 0.7×	726 0.7×	931 0.9×	503 0.8×	223 0.4×	61	2.4k
Leo Kager	1.2k 0.8×	589 0.5×	926 0.9×	443 0.7×	280 0.5×	100	2.7k
Beate Kempf‐Bielack	2.3k 1.4×	1.0k 0.9×	909 0.9×	605 1.0×	187 0.4×	17	3.4k
Mary Louise Keohan	2.8k 1.8×	2.2k 2.0×	673 0.6×	222 0.4×	769 1.4×	105	4.4k
Roman Kodet	815 0.5×	964 0.9×	1.3k 1.2×	316 0.5×	442 0.8×	171	3.1k
Herlinde Dumez	2.3k 1.5×	1.7k 1.5×	1.5k 1.4×	454 0.8×	150 0.3×	145	4.8k
Antonio López–Pousa	1.9k 1.2×	1.7k 1.5×	541 0.5×	273 0.5×	175 0.3×	161	3.4k
Joseph S. Palumbo	871 0.6×	1.5k 1.3×	820 0.8×	681 1.1×	455 0.9×	100	3.8k

Countries citing papers authored by Heribert Juergens

Since Specialization

Citations

This map shows the geographic impact of Heribert Juergens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Heribert Juergens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Heribert Juergens more than expected).

Fields of papers citing papers by Heribert Juergens

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Heribert Juergens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Heribert Juergens. The network helps show where Heribert Juergens may publish in the future.

Co-authorship network of co-authors of Heribert Juergens

This figure shows the co-authorship network connecting the top 25 collaborators of Heribert Juergens. A scholar is included among the top collaborators of Heribert Juergens based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Heribert Juergens. Heribert Juergens is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Deventer, Niklas, Georg Gosheger, Tymoteusz Budny, et al.. (2020). Aneurysmal bone cyst inadvertently treated with chemotherapy—A series of three cases. Pediatric Blood & Cancer. 67(10). e28638–e28638. 3 indexed citations

Worch, Jennifer, Andreas Ranft, Steven G. DuBois, et al.. (2018). Age dependency of primary tumor sites and metastases in patients with Ewing sarcoma. Pediatric Blood & Cancer. 65(9). e27251–e27251. 32 indexed citations

Scobioala, Sergiu, Andreas Ranft, Susanne Jabar, et al.. (2018). Impact of Whole Lung Irradiation on Survival Outcome in Patients With Lung Relapsed Ewing Sarcoma. International Journal of Radiation Oncology*Biology*Physics. 102(3). 584–592. 12 indexed citations

Krumbholz, Manuela, Tobias Bäuerle, Abbas Agaimy, et al.. (2016). Genomic EWSR1 Fusion Sequence as Highly Sensitive and Dynamic Plasma Tumor Marker in Ewing Sarcoma. Clinical Cancer Research. 22(17). 4356–4365. 61 indexed citations

Foulon, Stéphanie, Bernadette Brennan, Nathalie Gaspar, et al.. (2016). Can postoperative radiotherapy be omitted in localised standard-risk Ewing sarcoma? An observational study of the Euro-E.W.I.N.G group. European Journal of Cancer. 61. 128–136. 55 indexed citations

Andreou, Dimosthenis, Andreas Ranft, Daniel Baumhoer, et al.. (2016). Prognostic factors for local control in Ewing sarcoma (ES) in the Euro-EWING99 trial.. Journal of Clinical Oncology. 34(15_suppl). 11026–11026. 1 indexed citations

Altvater, Bianca, Sareetha Kailayangiri, Martina Ahlmann, et al.. (2014). Common Ewing sarcoma-associated antigens fail to induce natural T cell responses in both patients and healthy individuals. Cancer Immunology Immunotherapy. 63(10). 1047–1060. 18 indexed citations

Meyers, Paul A., et al.. (2013). Osteosarcoma treatment – Where do we stand? A state of the art review. Cancer Treatment Reviews. 40(4). 523–532. 1001 indexed citations breakdown →

Kailayangiri, Sareetha, Bianca Altvater, Jutta Meltzer, et al.. (2012). The ganglioside antigen GD2 is surface-expressed in Ewing sarcoma and allows for MHC-independent immune targeting. British Journal of Cancer. 106(6). 1123–1133. 104 indexed citations

10.

Pappo, Alberto S., Shreyaskumar Patel, John Crowley, et al.. (2011). R1507, a Monoclonal Antibody to the Insulin-Like Growth Factor 1 Receptor, in Patients With Recurrent or Refractory Ewing Sarcoma Family of Tumors: Results of a Phase II Sarcoma Alliance for Research Through Collaboration Study. Journal of Clinical Oncology. 29(34). 4541–4547. 252 indexed citations

11.

Juergens, Heribert, Najat C. Daw, Birgit Geoerger, et al.. (2011). Preliminary Efficacy of the Anti-Insulin–Like Growth Factor Type 1 Receptor Antibody Figitumumab in Patients With Refractory Ewing Sarcoma. Journal of Clinical Oncology. 29(34). 4534–4540. 165 indexed citations

12.

Rössig, Claudia, Heribert Juergens, & Wolfgang E. Berdel. (2011). New Targets and Targeted Drugs for the Treatment of Cancer: An Outlook to Pediatric Oncology. Pediatric Hematology and Oncology. 28(7). 539–555. 7 indexed citations

13.

Pfluger, Thomas, Kai Uwe Juergens, Regine Kluge, et al.. (2010). Empfehlungen zur Durchführung der Ganz körper-18F-FDG-PET und -PET/CT bei Kindern mit onkologischen Erkrankungen. Nuklearmedizin - NuclearMedicine. 49(6). 225–233. 5 indexed citations

14.

Vrachimis, Alexis, Uta Dirksen, Johannes Weßling, et al.. (2010). PET-Nachsorge von Patienten mit Ewing-Sarkomen am Körperstamm: Müssen die Unterschenkel berücksichtigt werden?. Nuklearmedizin - NuclearMedicine. 49(5). 183–186. 3 indexed citations

15.

Altvater, Bianca, Silke Landmeier, Sibylle Pscherer, et al.. (2009). 2B4 (CD244) Signaling by Recombinant Antigen-specific Chimeric Receptors Costimulates Natural Killer Cell Activation to Leukemia and Neuroblastoma Cells. Clinical Cancer Research. 15(15). 4857–4866. 165 indexed citations

16.

Brinkrolf, Peter, Silke Landmeier, Bianca Altvater, et al.. (2009). A high proportion of bone marrow T cells with regulatory phenotype (CD4+CD25^hiFoxP3+) in Ewing sarcoma patients is associated with metastatic disease. International Journal of Cancer. 125(4). 879–886. 46 indexed citations

17.

Ranft, Andreas, Georg Gosheger, Gabriele Braun‐Munzinger, et al.. (2009). The value of local treatment in patients with primary, disseminated, multifocal Ewing sarcoma (PDMES). Cancer. 116(2). 443–450. 108 indexed citations

18.

Landmeier, Silke, Bianca Altvater, Sibylle Pscherer, et al.. (2009). Activated Human γδ T Cells as Stimulators of Specific CD8+ T-cell Responses to Subdominant Epstein Barr Virus Epitopes. Journal of Immunotherapy. 32(3). 310–321. 28 indexed citations

19.

Kersting, Christian, Konstantin Agelopoulos, H Schmidt, et al.. (2008). Biological importance of a polymorphic CA sequence within intron 1 of the epidermal growth factor receptor gene (EGFR) in high grade central osteosarcomas. Genes Chromosomes and Cancer. 47(8). 657–664. 15 indexed citations

20.

Poremba, Christopher, Barbara Hero, Christina Scheel, et al.. (2001). Traditional and emerging molecular markers in neuroblastoma prognosis: The good, the bad and the ugly. Klinische Pädiatrie. 213(4). 186–190. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact